5.8(top 2%)
Impact Factor
6.6(top 2%)
extended IF
177(top 1%)
H-Index
4,995
authors
9,688
papers
331,461
citations
8,013
citing journals
83,301
citing authors

Most Cited Articles of Alimentary Pharmacology and Therapeutics in 2014

TitleYearCitations
Review article: the epidemiology and prevention of gastric cancer2014258
Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients2014257
Randomised clinical trial: The beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis2014255
Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease--the role of transient elastography and plasma cytokeratin-18 fragments2014243
Review article: the economic impact of the irritable bowel syndrome2014223
Systematic review: the role of the gut microbiota in chemotherapy- or radiation-induced gastrointestinal mucositis - current evidence and potential clinical applications2014206
Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease2014184
Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis2014169
Systematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitis2014165
Review article: The nutritional and pharmacological consequences of obesity surgery2014150
Review article: vitamin D and inflammatory bowel diseases2014137
Adalimumab drug and antibody levels as predictors of clinical and laboratory response in patients with Crohn's disease2014131
Review article: gastrointestinal angiodysplasia - pathogenesis, diagnosis and management2014127
Olmesartan-associated enteropathy: results of a national survey2014124
Review article: anti-adhesion therapies for inflammatory bowel disease2014124
Systematic review with network meta-analysis: the efficacy of anti-TNF agents for the treatment of Crohn's disease2014120
Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets2014111
Systematic review with meta-analysis: the effects of rifaximin in hepatic encephalopathy2014110
Systematic review with meta-analysis: malignancies with anti-tumour necrosis factor-α therapy in inflammatory bowel disease2014109
Systematic review with meta-analysis: associations between coeliac disease and type 1 diabetes2014108
Systematic review with network meta-analysis: the efficacy of anti-tumour necrosis factor-alpha agents for the treatment of ulcerative colitis2014108
Systematic review with meta-analysis: inflammatory bowel disease in the elderly2014104
Proton pump inhibitor-responsive oesophageal eosinophilia correlates with downregulation of eotaxin-3 and Th2 cytokines overexpression2014101
The impact of hepatitis C burden: an evidence-based approach201496
Systematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation201493